Home » Topics » Regulatory

Regulatory
RSS

Clinical trial results disappointing for Provigil as treatment for adult ADHD

Aug. 2, 2000

Vaniqa approved by FDA for women with unwanted facial hair

Aug. 2, 2000

Celecoxib in familial adenomatous polyposis

Aug. 1, 2000

Cimetidine as treatment for viral warts in children and adults

Aug. 1, 2000

Anticancer combinations with synergistic activity

July 31, 2000

Methods of treating CFS with 5-HT3 antagonists described by Novartis

July 31, 2000

Combined AT1 antagonist and immunosuppressant for GvHD complications

July 31, 2000

Tetracyclines as a valuable and relatively safe therapy for corneal ulceration

July 31, 2000

New dosage form, indication approved for Bayer's cerivastatin

July 28, 2000

Abbot's divalproex newly formulated for once-daily dosing

July 27, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...